Inti Zlobec

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Prognostic Factors

Cross Sectional

Top Venues

Journal of clinical pathology

Clinical epigenetics

International journal of colorectal disease

This page only lists publications with an associated author ORCID identifier.

Publications

Eva Karamitopoulou, Anna Silvia Wenning, Animesh Acharjee, Pauline Aeschbacher, Ilaria Marinoni, Inti Zlobec, Beat Gloor, Aurel Perren
Spatial heterogeneity of immune regulators drives dynamic changes of local immune responses, affecting disease outcomes in pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Magdalena Skoworonska, Annika Blank, Irene Centeno, Caroline Hammer, Aurel Perren, Inti Zlobec, Tilman T Rau
Real-life data from standardized preanalytical coding (SPREC) in tissue biobanking and its dual use for sample characterization and process optimization. The journal of pathology. Clinical research (2022)
Inti Zlobec, Melanie Bächli, Francesca Galuppini, Martin D Berger, Heather E Dawson, Iris D Nagtegaal, Alessandro Lugli
Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer. Virchows Archiv : an international journal of pathology (2021)
Viktor Hendrik Koelzer, Rainer Grobholz, Inti Zlobec, Andrew Janowczyk, null null
Update on the current opinion, status and future development of digital pathology in Switzerland in light of COVID-19. Journal of clinical pathology (2021)
Che-Jui Lee, Agnieszka Wozniak, Thomas Van Cann, Iris Timmermans, Jasmien Wellens, Ulla Vanleeuw, Inge H Briaire-de Bruijn, Christian Britschgi, Judith V M G Bovée, Inti Zlobec, Raf M E Sciot, Patrick Schöffski
Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research. Sarcoma 2021 (2021)
Palanivel Kandasamy, Inti Zlobec, Damian T Nydegger, Jonai Pujol-Giménez, Rajesh Bhardwaj, Senji Shirasawa, Toshiyuki Tsunoda, Matthias A Hediger
Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1. Molecular oncology 15 (10) (2021)
Nadine D F Georges, Beatrice Oberli, Tilman T Rau, José A Galván, Iris D Nagtegaal, Heather Dawson, Annika Blank, Andreas Kohler, Alessandro Lugli, Inti Zlobec
Tumour budding and CD8+ T cells: 'attackers' and 'defenders' in rectal cancer with and without neoadjuvant chemoradiotherapy. Histopathology 78 (7) (2021)
Julia Unternaehrer, Rainer Grobholz, Andrew Janowczyk, Inti Zlobec, null null
Current opinion, status and future development of digital pathology in Switzerland. Journal of clinical pathology 73 (6) (2019)
Joël L Lavanchy, Lukas Vaisnora, Tobias Haltmeier, Inti Zlobec, Lukas E Brügger, Daniel Candinas, Beat Schnüriger
Oncologic long-term outcomes of emergency versus elective resection for colorectal cancer. International journal of colorectal disease 34 (12) (2019)
Janina Graule, Kristin Uth, Elia Fischer, Irene Centeno, José A Galván, Micha Eichmann, Tilman T Rau, Rupert Langer, Heather Dawson, Ulrich Nitsche, Peter Traeger, Martin D Berger, Beat Schnüriger, Marion Hädrich, Peter Studer, Daniel Inderbitzin, Alessandro Lugli, Mario P Tschan, Inti Zlobec
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway. Clinical epigenetics 10 (1) (2018)